Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Arthritis, Rheumatoid × Exercise × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 209 Breast Neoplasms 116 Neoplasms 90 Prostatic Neoplasms 33 Fatigue 28 Obesity 22 Colorectal Neoplasms 20 Lung Neoplasms 15 Colonic Neoplasms 15 Polycystic Ovary Syndrome 13 Ovarian Neoplasms 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Lymphedema 10 Head and Neck Neoplasms 10 Rectal Neoplasms 9 Lymphoma 9 Hematologic Neoplasms 9 Weight Loss 8 Multiple Myeloma 8 Leukemia 8 Cardiotoxicity 8 Brain Neoplasms 8 Pancreatic Neoplasms 7 Insulin Resistance 7 Carcinoma, Non-Small-Cell Lung 7 Cognitive Dysfunction 6 Sarcopenia 5 Peripheral Nervous System Diseases 5 Overweight 5 Lymphoma, Follicular 5

Interventions

Adalimumab 14 Etanercept 13 Methotrexate 9 tocilizumab 7 golimumab 6 Infliximab 6 tofacitinib 5 Rituximab 5 Tumor Necrosis Factor Inhibitors 4 Abatacept 4 olokizumab 3 Certolizumab Pegol 3 RC-18 2 Nivolumab 2 Antirheumatic Agents 2 veltuzumab 1 upadacitinib 1 secukinumab 1 sarilumab 1 mavrilimumab 1 entecavir 1 baricitinib 1 andecaliximab 1 Vitamin D 1 Surveys and Questionnaires 1 Sulfasalazine 1 Standard of Care 1 Specimen Handling 1 Saline Solution 1 Radioimmunodetection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05215509 2024-02-02

RABEX

Rigshospitalet, Denmark

Phase NA Completed

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡